The Science Behind Libido-Boosting Medication

The drug will be on sale in the US from October.

Find out if treatment is right for you.

Evidence of the drug's safety and efficacy has not improved since it was last rejected, and many have suggested that the FDA approval was a result of a sustained lobbying campaign by drug makers. Sprout Pharmaceuticals helped launch a public relations campaign called "Even the Score" which accused the FDA of sexism for only having ever approved drugs to treat male sexual dysfunction. "The FDA has turned this down twice before, and now we have no new evidence of benefits, and we have more evidence of harms, so if the FDA does approve the drug today the only thing that changed is the amount of pressure put on it by a corporation though a major PR campaign," said Fugh-Berman. Amy Allina, deputy director of the National Women’s Health Network said that while she agrees with the pharmaceutical company that women deserve to have their sexual problems taken seriously – "we do not believe that a minimally effective drug that must be taken daily, causes significant side effects and has not been evaluated for long-term safety, offers women a serious solution." It is the small pink pill that its manufacturers hope will do for women what Viagra did for men. The decision to give the drug a marketing licence in the US has been cheered on by campaigners for women’s rights, but the question remains whether Addyi is the breakthrough medicine claimed.

Comparison table

Men have the blue diamond-shaped Viagra pill and 25 others (although 17 of those are forms of testosterone), while there has until now been no counterpart for women. But sex and relationship therapists say Addyi is only moderately effective, should not be taken viagra 100mg with alcohol, and has potentially serious side-effects. Trials showed that Addyi gave women who took it daily one extra sexually satisfying experience per month. Some of the women who testified before the US drug licensing committee, the Food and Drug Administration, seemed to believe the pill would bring back the passion and romance of times past, but there are fears they are being sold an unfulfillable dream. “I am concerned about the expectations that women have,” said Cynthia Graham, professor in sexual and reproductive health at the University of Southampton. Sprout has not said whether it will

Product	Dosage	Quantity + Bonus	Price
Viagra Super Active	100mg	90 + 10 Pills	165.61€ 157.72€	Buy
Viagra Professional	100mg	20 Pills	71.14€ 67.75€	Buy
Viagra Oral Jelly	100mg	220 + 18 Sachets	562.28€ 535.50€	Buy
Viagra Generic	150mg	90 + 6 Pills	147.18€ 140.17€	Buy
Viagra Super Active	100mg	60 + 8 Pills	116.84€ 111.28€	Buy
Viagra Generic	150mg	20 Pills	55.02€ 52.40€	Buy
Viagra Generic	50mg	90 + 6 Pills	107.37€ 102.26€	Buy
Viagra Original	100mg	76 + 4 Pills	306.59€ 291.99€	Buy
Viagra Soft Tabs	100mg	30 + 4 Pills	83.06€ 79.10€	Buy
Viagra Soft Tabs	100mg	60 + 6 Pills	152.94€ 145.66€	Buy
Viagra Generic	25mg	120 + 6 Pills	125.56€ 119.58€	Buy
Viagra Super Active	100mg	270 + 30 Pills	390.61€ 372.01€	Buy
Viagra Soft Tabs	100mg	270 + 10 Pills	419.95€ 399.95€	Buy
Viagra Generic	25mg	180 + 6 Pills	154.93€ 147.55€	Buy
Viagra Generic	25mg	90 + 6 Pills	105.03€ 100.03€	Buy

apply for a licence to sell it

Real Science. Real Results.

Addyi will have a black box warning, meaning there are serious side-effects. It is not approved for women past the menopause or anyone with an impaired liver. It can cause low blood pressure and loss of consciousness. Those risks are higher if women drink. “Because of a potentially serious interaction with alcohol, treatment with Addyi will only be available through certified health care professionals and certified pharmacies,” said Dr Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research.

Side effects

“Patients and prescribers should fully understand the risks associated with the use of Addyi before considering treatment.” The FDA wants Sprout to do further studies of the impact of alcohol. The one it carried out involved 25 people, of whom 23 were men. Graham believes there is little chance doctors will hold off prescribing it for women who drink or who are post-menopause. Even in the hours after the announcement of the licence “we could see signs that the drug is not going to be prescribed only to women who are pre-menopausal and don’t drink”, she said. Dr Irwin Goldstein, who heads the San Diego sexual medicine centre and has been a consultant to Sprout, told the New York Times he would not refuse to give it to casual drinkers. in Europe, but if it did, the verdict might not necessarily be the same.

DARE to PLAY Sildenafil Cream

They wonder, ‘Will my partner leave me?’ and, ‘Am I undesirable or inadequate?’” There are some who wonder if they are missing out on pleasure, she said, but that was not their main anxiety. “They are talking about not being good enough or not measuring up. People have a perception that everybody else is having fantastic sex all the time with exotic positions.” There is, Boynton said, “anxiety brought about by misinformation about sex”, which is perpetuated by the media and especially men’s and women’s magazines. “The cultural wallpaper is telling you that to keep someone and be desirable and not left alone, which is a huge fear, you must be having and providing frequent sex.” Addyi could help a small number of women, but Boynton pointed out that, like the other drugs for sexual problems, it had only been tested against placebos. It would have been interesting, she said, to trial it against candles and bathnights and sex toys – and, for that matter, relationship therapy. “I would be surprised if

The Sexy Science Behind Dare to Play

There are also questions about the true scale of unmet need. The often used statistic that more than two-fifths of all women – 43% – experience loss of sexual desire dates from a survey in 1999 which failed to ask women whether they were actually worried by that. The bigger and more recent National Attitudes and Sexual Lifestyles study in the UK found that about 10% of women had low libido and were experiencing distress as a result. Dr Petra Boynton, an agony aunt and psychologist who has researched sexual functioning, says losing interest in sex is a real worry for women, “But what are they actually worried about? They think they are not normal because they don’t want sex that much. it is licensed here,” said Boynton.

Videos by VICE

Dr Lauren Streicher of Northwestern University told NBC News that the FDA approval is a "huge advancement" in women's health. "As a sexual health expert, as a gynaecologist, as someone who takes care of women every single day, this is going to be a game changer for me because right now I have women that come into my office and have a distressing lack of sexual desire and I just say, 'I'm so sorry. There is nothing that I can do.'" A free daily email with the biggest news stories of the day – and the best features from TheWeek.com But critics argue that the drug is simply not effective enough. According to FDA analysis, only between 8 and 13 percent of women who take the pill will see some improvement. "That's a pretty small number, particularly when you consider how "improvement" has been defined," says Vox.

11 natural aphrodisiacs for females

Women taking the pill have on average just 0.5 more "sexually satisfying events" per month. Dr. Adriane Fugh-Berman from Georgetown University has described the drug as "a mediocre aphrodisiac with scary side effects". These include very low blood pressure, dizziness, sleepiness and even loss of consciousness. Drinking alcohol and taking some forms of birth control will increase the risk of the side-effects. “But whether it is licensed or

• Filbanserin typically takes 4-8 weeks of daily use to show any potential effect.
• Bremelanotide is used as needed, with an injection approximately 45 minutes before sex.
• Effects of a single Vyleesi injection are intended to last for about 8-12 hours.
• Ospemifene is a daily tablet that requires ongoing use to maintain its effects.
• Topical estrogen treatments often show improvement in dryness within a few weeks.
• Testosterone therapy may take several months to potentially influence libido.
• Psychological therapies require a longer-term commitment for sustainable results.

not, it will still perpetuate the

• A GP is the first point of contact for discussing sexual health concerns in the UK.
• They may conduct blood tests to check hormone levels (e.g., testosterone, estrogen).
• A full medical and psychological history is essential for an accurate diagnosis.
• GPs can refer patients to a specialist clinic, like a urogynaecology or sexual health service.
• Specialists may work in NHS hospitals or private practices.
• The British Society for Sexual Medicine provides guidelines for healthcare professionals.
• A diagnosis often involves ruling out other medical and relationship issues first.

illusion that if you don’t have

• HSDD (Hypoactive Sexual Desire Disorder) is a common condition characterized by low libido.
• FSAD (Female Sexual Arousal Disorder) involves difficulty achieving or maintaining arousal.
• Female Orgasmic Disorder is the persistent difficulty in achieving orgasm.
• Genitourinary Syndrome of Menopause (GSM) causes vaginal dryness and pain.
• Underlying medical conditions like diabetes or thyroid issues can affect sexual function.
• Medications, particularly antidepressants (SSRIs), are a common cause of low libido.
• Psychological causes include stress, anxiety, body image issues, or past trauma.

desire, there is something wrong with you.”

Where the Magic Happens

However, Ms Marescotti notes that “those hoping for a ‘female Viagra’ will be disappointed. In contrast to erectile dysfunction, she adds that “the complicated nature of FSD means that a quick fix in the form of an effective pill is very hard to achieve”. Flibanserin has finally been approved by the US drugs agency – but only after two unsuccessful attempts The first drug to treat a lack of sexual desire in women has been approved by the US Food and Drug Administration, but it continues to divide medical professionals. "Today's approval provides women distressed by their low sexual desire with an approved treatment option," said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research. But Flibanserin has already been rejected twice by the drugs agency and there are widespread concerns about the safety and efficacy of the much-anticipated pill nicknamed the "female Viagra".

How it Helps You Do It

From our daily WeekDay news briefing to an award-winning Food & Drink email, get the best of The Week delivered directly to your inbox. What is it and how does it work? The drug, sold under the brand name Addyi and produced by Sprout Pharmaceuticals, is designed to treat low libido in premenopausal women. One small pink pill is taken daily by women who have been diagnosed with Hypoactive Sexual Desire Disorder. Unlike Viagra, the drug does not relax muscles or increase blood flow, but changes brain chemistry similar to the way that antidepressants do, The Guardian reports. 1970 Masters and Johnson publish “Human

Off-Label Use	Potential Risks	Medical Advice
Sildenafil for Female Libido	Cardiovascular side effects, interactions with other meds	Always consult a doctor before use
Non-approved supplements	Unknown composition, higher risk of adverse reactions	Use only if prescribed by a healthcare professional
DIY formulations	Dangerous, no clinical testing	Highly discouraged

Sexual Inadequacy”, the result of over

Ready to see why DARE to PLAY could be the best you've ever had?

“Among women who spoke at the FDA, there were expectations that you can have sexual desire that is at a high level and nothing is going to affect it – that it will be right back where it was when you met your partner.” Graham and other critics believe the FDA was pressured and half-shamed into approving Addyi (generic name flibanserin) by a campaign headed by a vocal group called Even the Score, which pitched the absence of drugs to help women with low libido as a gender inequality issue. It describes itself as a campaign for women’s sexual health equality which was “created to serve as a voice for American women who believe that it’s time to level the playing field when it comes to the treatment of women’s sexual dysfunction”. On the front page of its website now runs a banner saying “Thank you, FDA”. Sprout Pharmaceuticals, which owns Addyi, is one of the funders, as is Trimel, another company in the same field. Its shareholders should be in for a windfall if the drug produces even a fraction of the success and profits Viagra did for Pfizer.

What causes low libido in women?

Sprout’s chief executive, however, hailed the FDA decision as a victory for women. “It has been a remarkable journey to get to this breakthrough moment. Today we celebrate what this approval means for all women who have long awaited a medical treatment option for this life impacting condition,” said Cindy Whitehead. “We applaud the FDA for putting the patient voice at the center of the conversation and for focusing on scientific evidence.” The drug, an antidepressant that works on the brain, unlike Viagra, was rejected twice by the FDA on the basis of a small benefit and substantial side-effects. The final vote was 18 to 6, with none of the panel willing to endorse it without caveats. a decade of work at the

• The first FDA-approved female libido drug was flibanserin, marketed as Addyi in the US and sometimes available in the UK.
• Female Viagra aims to target conditions like low libido, which can be caused by hormonal or psychological issues.
• The effectiveness of female Viagra varies between individuals; some report notable improvements.
• Cost of female libido medications in the UK varies and may not be covered by NHS prescriptions.
• Researchers continue to explore new treatments for female sexual dysfunction with promising results.
• Natural alternatives include herbal supplements like ginseng or maca, but their efficacy is not well-proven.
• Discussing sexual health openly with a healthcare professional is recommended before starting treatment.
• Some women use off-label medications or supplements to boost libido, but safety isn't always assured.
• Female Viagra is not suitable for everyone; medical history and other medications should be considered.

Reproductive Biology Research Foundation in St Louis.

Trend	Description	Expected Developments
Increased regulatory approval	More medications gaining approval	Expanded options for women
Personalized treatment plans	Based on genetic and hormonal profiles	Customized therapies
Natural and organic products	Growing popularity among health-conscious consumers	Rise of herbal and plant-based solutions